Distribution of Metastatic Disease in Survival Outliers with Stage IV Non-Small Cell Lung Cancer

被引：0
|
作者：
Fung, A. [1 ]
D'Silva, A. [2 ]
Li, H. [1 ]
Otsuka, S. [1 ]
Bebb, D. G. [2 ]
机构：
[1] Univ Calgary, Calgary, AB, Canada
[2] Univ Calgary, TBCC Translat Labs, Oncol, Calgary, AB, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Survival Outliers; Stage IV NSCLC; Metastatic Disease;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-026
引用
收藏
页码：S2077 / S2078
页数：2
相关论文
共 50 条
  • [41] Treatment Initiation, Tolerance and Survival in Elderly Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC)
    Helfrich, G.
    Gijtenbeek, R. G.
    Venmans, B. J.
    Ten Brinke, A.
    De Jong, K.
    van Geffen, W. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [42] Non-Small Cell Lung Cancer Stage IV Long-Term Survival With Isolated Spleen Metastasis
    Sardenberg, Rodrigo A. S.
    Pinto, Clovis
    Bueno, Cynthia A.
    Younes, Riad N.
    ANNALS OF THORACIC SURGERY, 2013, 95 (04): : 1432 - 1434
  • [43] Feasibility and Survival Outcomes of "Salvage Surgery" for Initially Clinical Stage IV Non-small Cell Lung Cancer
    Hishida, T.
    Oka, N.
    Okubo, Y.
    Masai, K.
    Kaseda, K.
    Asamura, H.
    Asakura, K.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S592 - S593
  • [44] Nivolumab timing as a major survival predictor in patients with stage IV non-small cell lung cancer.
    Karaboue, Abdoulaye
    Collon, Thierry
    Bodiguel, Viviane
    Cucherousset, Joel
    Innominato, Pasquale
    Bouchahda, Mohamed
    Adam, Rene
    Levi, Francis
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] PLATINUM BASED CHEMOTHERAPY IN STAGE IIIB AND IV NON-SMALL CELL LUNG CANCER (NSCLC) - THE EFFECT ON SURVIVAL
    Mobarek, N. A.
    LUNG CANCER, 2009, 64 : S57 - S57
  • [46] Effect of delaying chemotherapy on survival outcomes in the treatment of stage IV non-small cell lung cancer.
    Mozayen, Mohammad
    Alsharedi, Mohamed Farouq
    Mehmi, Inderjit
    Gress, Todd W.
    Tirona, Maria R. B. Tria
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [47] Effect of primary tumor volume on survival of concurrent chemoradiotherapy in stage IV non-small cell lung cancer
    Chen, Xiaxia
    Zhang, Wei
    Luo, Lan
    Fu, Shimei
    Cao, Dongdong
    Su, Shengfa
    Li, Qingsong
    Yang, Wengang
    Geng, Yichao
    Lu, Bing
    Ouyang, Weiwei
    CANCER MEDICINE, 2024, 13 (17):
  • [48] Prognostic factors for short-term survival in patients with stage IV non-small cell lung cancer
    Ando, M
    Ando, Y
    Sugiura, S
    Minami, H
    Saka, H
    Sakai, S
    Shimokata, K
    Hasegawa, Y
    JAPANESE JOURNAL OF CANCER RESEARCH, 1999, 90 (02): : 249 - 253
  • [49] Biologically Active Volume of Disease (BaVD) Predicts for Survival in Metastatic Non-Small Cell Lung Cancer
    Du, D.
    Abuali, T.
    Ladbury, C. J.
    Liu, J. R.
    Liu, A.
    Watkins, W. T.
    Massarelli, E.
    Villaflor, V. M.
    Salgia, R.
    Williams, T. M.
    Glaser, S. M.
    Amini, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E427 - E427
  • [50] SURVIVAL IN COPD PATIENTS WITH STAGE 1 NON-SMALL CELL LUNG CANCER
    Thiruchelvam, Nirosshan
    Sarda, Yash
    Han, Xiaozhen
    Wang, Xiaofeng
    Mazzone, Peter
    CHEST, 2020, 158 (04) : 1463A - 1463A
12345